Product Information
QC INF IBUPROFEN 50 MG/1.25 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.2010 per ML under NDC 83324000530. Its NADAC has been published 75 times since Dec 18, 2024.
Strength
50 mg/1.25mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324000530
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA210755On Market Since
11/3/2023
Pharmacological Classes
Price Statistics
The NADAC for QC INF IBUPROFEN 50 MG/1.25 ML has been published 75 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2010 per ML |
|---|---|
| All-time high | $0.2035 (Jun 11, 2025) |
| All-time low | $0.1984 (Dec 18, 2024) |
| 52-week high | $0.2034 |
| 52-week low | $0.1994 |
| Median price | $0.2012 |
| Average price | $0.2013 |
| Largest weekly change | -0.9% (Dec 17, 2025) |
| Weeks tracked | 75 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC INF IBUPROFEN 50 MG/1.25 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC INF IBUPROFEN 50 MG/1.25 ML, manufactured by Chain Drug Marketing Association, is $0.2010 per ML (NDC 83324000530), effective May 20, 2026.
How has the price of QC INF IBUPROFEN 50 MG/1.25 ML changed over time?
Over the history we have for it, the NADAC for QC INF IBUPROFEN 50 MG/1.25 ML has held within roughly two percent of its current level. It has been tracked across 75 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for QC INF IBUPROFEN 50 MG/1.25 ML?
Since Dec 18, 2024, the NADAC for QC INF IBUPROFEN 50 MG/1.25 ML has ranged from a low of $0.1984 (Dec 18, 2024) to a high of $0.2035 (Jun 11, 2025), with a median of $0.2012 per ML.
Are there cheaper alternatives to QC INF IBUPROFEN 50 MG/1.25 ML?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, INFANT IBUPROFEN 50 MG/1.25 ML, is $0.1880 per ML — about 6% below QC INF IBUPROFEN 50 MG/1.25 ML.
Who manufactures QC INF IBUPROFEN 50 MG/1.25 ML?
QC INF IBUPROFEN 50 MG/1.25 ML (NDC 83324000530) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification